Cargando…
Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases
BACKGROUND: Patients with prostate cancer is commonly diagnosed with bone metastases. With the growing use of prostate-specific antigen testing, the frequency of prostate cancer has progressively increased in patients younger than 70 years. Radiotherapy is recognized for its effect on local control...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847259/ https://www.ncbi.nlm.nih.gov/pubmed/27116938 http://dx.doi.org/10.1186/s12967-016-0868-y |